⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 6, 2024BMC NephrologyOpen Access

Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001–2018

Zhongcheng Fan Rugang Li Miaoxia Pan Yangyang Jiang Ying Li Li Liu Yang Li

View Full Paper

Ask AI

Bookmark

Share

Abstract

Hyperphosphatemia is common in chronic kidney disease (CKD), associated with higher mortality in dialysis patients. Its impact in non-dialysis patients, especially those with preserved kidney function, remains uncertain.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fan et al. (2024) studied this question.

synapsesocial.com/papers/68e7569cb6db6435876cea6c https://doi.org/10.1186/s12882-024-03525-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Patient characteristics modify the association between changes in mineral metabolism parameters and mortality in a nationwide hemodialysis cohort studyPrognostic Study · 2025
2Association between serum phosphate levels within the normal range and all-cause mortality among US adultsCohort Study · 2026
3Real-world assessment of elevated serum alkaline phosphatase and hyperphosphatemia as predictors of mortality in non-dialysis chronic kidney disease patients: a hospital-based prospective cohort studyCohort Study · 2026
4Correlation between serum phosphate and all-cause mortality in critically ill patients with coronary heart disease accompanied by chronic kidney disease: a retrospective study using the MIMIC-IV database2024 · 7 citations
5Exploring the association between serum phosphate levels and mortality in patients hospitalized with infectious diseases: a nationwide study2024 · 4 citations